guest ::
000815030 001__ 815030 000815030 005__ 20220818125752.0 000815030 0247_ $$2HSB$$aeva33198 000815030 0247_ $$2ISSN$$a0031-7098 000815030 0247_ $$2ISSN$$a0176-3679 000815030 0247_ $$2ISSN$$a0720-4280 000815030 0247_ $$2ISSN$$a1439-0795 000815030 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85084190655 000815030 0247_ $$2WOS$$aWOS:000531336700004 000815030 0247_ $$2doi$$a10.1055/a-1110-1010 000815030 0247_ $$2pmid$$apmid:32106330 000815030 037__ $$aRWTH-CONV-244890 000815030 041__ $$aEnglish 000815030 1001_ $$aStingl, Julia C.$$b0$$eCorresponding author$$urwth 000815030 245__ $$aPrevalence of Psychotropic Drugs in Cases of Severe Adverse Drug Reactions Leading to Unplanned Emergency Visits in General Hospitals$$honline, print 000815030 260__ $$aStuttgart [u.a.]$$bThieme$$c2020 000815030 3367_ $$00$$2EndNote$$aJournal Article 000815030 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal 000815030 3367_ $$2BibTeX$$aARTICLE 000815030 3367_ $$2DRIVER$$aarticle 000815030 3367_ $$2DataCite$$aOutput Types/Journal article 000815030 3367_ $$2ORCID$$aJOURNAL_ARTICLE 000815030 591__ $$aGermany 000815030 7001_ $$aJust, Katja S.$$b1$$urwth 000815030 7001_ $$aSchurig, Marlen$$b2 000815030 7001_ $$aBöhme, Miriam$$b3 000815030 7001_ $$aSteffens, Michael$$b4 000815030 7001_ $$aSchwab, Matthias$$b5 000815030 7001_ $$aSeufferlein, Thomas$$b6 000815030 7001_ $$aDormann, Harald$$b7 000815030 773__ $$0PERI:(DE-600)2041961-2$$a10.1055/a-1110-1010$$n3$$p133-137$$tPharmacopsychiatry$$v53$$x1439-0795 000815030 9141_ $$y2020 000815030 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0 000815030 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-30$$wger 000815030 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPHARMACOPSYCHIATRY : 2019$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-30 000815030 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-01-30 000815030 9201_ $$0I:(DE-82)528500-3_20140620$$k528500-3$$lInstitut und Lehrstuhl für Klinische Pharmakologie$$x0 000815030 961__ $$c2021-03-02$$x2021-03-09 000815030 970__ $$aeva33198 000815030 980__ $$aI:(DE-82)528500-3_20140620 000815030 980__ $$aIMPORT 000815030 980__ $$aUNRESTRICTED 000815030 980__ $$aVDBINPRINT 000815030 980__ $$ajournal